OFFICIAL PUBLICATION OF

pdl.com.au

by its subsidiary APPco

A new name

Sheshtyn Paola 20/08/2021

AstraZeneca has officially changed the name of its COVID-19 vaccine AstraZeneca has now registered the brand name Vaxzevria for its COVID-19 vaccine. The TGA approved the name change on Thursday for the product previously named COVID-19 Vaccine AstraZeneca. It is estimated that supply in Australia of the Vaxzevria-branded product will commence in late 2021. Once supply of

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

Funding secured for non-8CPA programs

Medschecks and Diabetes MedsCheck are included and funded under the 8CPA. The programs under the 8CPA will be undergoing a…

Anthony Tassone

Eli Lilly clarifies Mounjaro availability

One would think they could have made a commercial decision eith a needle maker to supply requisite number of needles…

Erin Threlfall

Funding secured for non-8CPA programs

This is a big step forward in securing the sustainability and viability of HMRs and RMMRs. Remember there is an…

Debbie Rigby

Funding secured for non-8CPA programs

So well done to the PSA for securing this funding. So important that these very valuable program finally gets looked…

Bente Hart